Clinical Trial Update: PREventing Second Cancers With DOSTARlimab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dostarlimab (DOSTARlimab) to prevent second cancers is currently recruiting at Centre Léon Bérard for patients with recurrent or primar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: Centre Leon Berard | Conditions: Recurrent Cancer, Primary Cancer | Phase 2 | Status: RECRUITING